Author response for 'REAL‐WORD EXPERIENCE WITH DECITABINE AS A FIRST‐LINE TREATMENT IN 306 ELDERLY ACUTE MYELOID LEUKAEMIA PATIENTS UNFIT FOR INTENSIVE CHEMOTHERAPY'

Autor:	Michela Rondoni, Elisabetta Todisco, Daniela Lambertenghi Deliliers, Catia Bigazzi, Barbara Scappini, Michele Gottardi, Massimo Bernardi, Francesco Mazziotta, Maria Grazia Michieli, Giuseppe Rossi, Marianna Rossi, Marta Riva, Gianpaolo Nadali, Eros Di Bona, Anna Candoni, Emanuela Caizzi, Renato Fanin, Monica Fumagalli, Margherita Sciumé, Alfredo Molteni, Claudia Basilico, Monica Bocchia, Carla Filì, Giulia Fontanelli, Nicola Stefano Fracchiolla, Ugo Consoli, Vincenzo Sammartano, Erika Borlenghi, Francesco Rotondo, Roberto Latagliata, Giulia Alunni, Carlotta Galeone, Silvia Imbergamo, Chiara Cattaneo, Claudio Pelucchi, Enrico Capochiani, Anna Ermacora, Marzia Defina, Giuseppina Greco, Federico Simonetti, Monica Crugnola, Anna Sicuranza
Rok vydání:	2019
Předmět:	First line treatment Oncology medicine.medical_specialty business.industry Internal medicine Medicine Decitabine Intensive chemotherapy Real word Myeloid leukaemia business medicine.drug
DOI:	10.1002/hon.2663/v2/response1
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::83498a98f0725c866016b0430e96e892 https://doi.org/10.1002/hon.2663/v2/response1 Zobrazit plný text záznamu